Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Hematology-Oncology

Merck & Co is expediting plans to submit FDA approval applications for new hepatitis C and lung cancer treatments, Reuters reports. The company plans to file a drug approval application midyear to extend the use of new cancer immunotherapy Keytruda, a...
According to Reuters, the new Amgen leukemia drug being released today will cost about $178,000, spread over two $89,000 treatment cycles. The price tag will place the drug amongst the world’s most expensive cancer drugs. Blincyto will be used to...
According to CBS News, nivolumab, a PD-1 blocking drug may help patients with Hodgkin lymphoma who saw little or no effect with other therapies. A study published in the New England Journal of Medicine looked at 23 patients with the disease who were...